Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now Jan 14, 2025 07:00AM
Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification Jan 13, 2025 08:00AM
Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products Jan 6, 2025 08:00AM
CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing Dec 16, 2024 08:00AM
A Letter from the Desk of CBIH Dec 9, 2024 08:00AM


Dec 4, 2024 07:00AM Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now
Dec 2, 2024 08:00AM CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing
Nov 25, 2024 08:00AM CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip
Nov 18, 2024 08:00AM CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions
Nov 12, 2024 08:00AM Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44
Jul 15, 2024 08:00AM CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications
Jul 8, 2024 08:00AM CBIH Charts Path to Future Leadership in Cannabis Medicine
Jul 1, 2024 08:00AM CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
Jun 26, 2024 10:52AM CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
Jun 17, 2024 09:50AM Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
Jun 5, 2024 03:12PM CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward